Beneficial effects of melatonin on serum nitric oxide, homocysteine, and ADMA levels in fructose-fed rats

References

• Araki A, Sako Y. (1987). Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422:43–52
   PubMed Web of Science ®Google Scholar
• Assumpçao CR, Brunini TMC, Matsuura C, Mendes-Riberio AC. (2008). Impact of the l-arginine-nitric oxide pathway and oxidative stress on the pathogenesis of the metabolic syndrome. Open Biochem J 2:108–15
   PubMedGoogle Scholar
• Bestermann WH. (2011). The ADMA–metformin hypothesis: Linking the cardiovascular consequences of the metabolic syndrome and type II diabetes. Cardiorenal Med 1:211–19
   PubMed Web of Science ®Google Scholar
• Bezerra RM, Ueno M, Silva MS, et al. (2000). A high fructose diet affects the early steps of insulin action in muscle and liver of rats. J Nutr 130:1531–5
   PubMed Web of Science ®Google Scholar
• Cardinali DP, Bernasconi PA, Reynoso R, et al. (2013). Melatonin may curtail the metabolic syndrome: Studies on initial and fully established fructose-induced metabolic syndrome in rats. Int J Mol Sci 14:2502–14
   PubMed Web of Science ®Google Scholar
• Castro MC, Massa ML, Schinella G, et al. (2013). Lipoic acid prevents liver metabolic changes induced by administration of a fructose-rich diet. Biochim Biophys Acta 1830:2226–32
   PubMed Web of Science ®Google Scholar
• Chan TY, Tang PL. (1995). Effect of melatonin on the maintenance of cholesterol homeostasis in the rat. Endocr Res 21:681–96
   PubMed Web of Science ®Google Scholar
• Chen BM, Xia LW, Zhao RQ. (1997). Determination of N(G),N(G)-dimethylarginine in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 692:467–71
   PubMed Web of Science ®Google Scholar
• Dai S, McNeill JH. (1995). Fructose-induced hypertension in rats is concentration and duration dependent. J Pharmacol Toxicol Methods 33:101–7
   PubMed Web of Science ®Google Scholar
• Dayal S, Lentz SR. (2005). ADMA and hyperhomocysteinemia. Vasc Med 10:S27–33
   Web of Science ®Google Scholar
• Dayal S, Arning E, Bottiglieri T, et al. (2004). Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke 35:1957–62
   PubMed Web of Science ®Google Scholar
• de Moura RF, Ribeiro C, de Oliveira JA, et al. (2009). Metabolic syndrome signs in Wistar rats submitted to different high fructose ingestion protocols. Br J Nutr 101:1178–84
   PubMed Web of Science ®Google Scholar
• Delbosc S, Paizanis E, Magous R, et al. (2005). Involvement of oxidative stress and NADPH oxidase activation in the development of cardiovascular complications in a model of insulin resistance, the fructose-fed rat. Atherosclerosis 179:43–9
   PubMed Web of Science ®Google Scholar
• Elliott SS, Keim NL, Stern JS, et al. (2002). Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 76:911–22
   PubMed Web of Science ®Google Scholar
• Ersahin M, Sehirli O, Toklu HZ, et al. (2009). Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension. J Pineal Res 47:97–106
   PubMed Web of Science ®Google Scholar
• Giani JF, Mayer MA, Munoz MC, et al. (2009). Chronic infusion of angiotensin-(1–7) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am J Physiol Endocrinol Metab 296:E262–71
   PubMed Web of Science ®Google Scholar
• Glushakova O, Kosugi T, Roncal C, et al. (2008). Fructose induces the inflammatory molecule ICAM-1 in endothelial cells. J Am Soc Nephrol 19:1712–20
   PubMed Web of Science ®Google Scholar
• Hanson RL, Imperatore G, Bennett PH, Knowler WC. (2002). Components of the metabolic syndrome and incidence of type 2 diabetes. Diabetes 51:3120–7
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Segal MS, Sautin Y, et al. (2007). Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease and cardiovascular disease. Am J Clin Nutr 86:899–906
   PubMed Web of Science ®Google Scholar
• Kamata K, Yamashita K. (1999). Insulin resistance and impaired endothelium-dependent renal vasodilatation in fructose-fed hypertensive rats. Res Commun Mol Pathol Pharmacol 103:195–210
   PubMedGoogle Scholar
• Kim EH, Koh EH, Park JY, Lee KU. (2010). Adenine nucleotide translocator as a regulator of mitochondrial function: Implication in the pathogenesis of metabolic syndrome. Korean Diabetes J 34:146–53
   PubMedGoogle Scholar
• Kitagava A, Ohta Y, Ohashi K. (2012). Melatonin improves metabolic syndrome induced by high fructose intake in rats. J Pineal Res 52:403–13
   PubMed Web of Science ®Google Scholar
• Kozirog M, Poliwczak AR, Duchnowicz P, et al. (2011). Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res 50:261–6
   PubMed Web of Science ®Google Scholar
• Leibowitz A, Peleg E, Sharabi Y, et al. (2008). The role of melatonin in the pathogenesis of hypertension in rats with metabolic syndrome. Am J Hypertens 21:348–51
   PubMed Web of Science ®Google Scholar
• Marchesi C, Ebrahimian T, Angulo O, et al. (2009). Endothelial nitric oxide synthase uncoupling and perivascular adipose oxidative stress and inflammation contribute to vascular dysfunction in a rodent model of metabolic syndrome. Hypertension 54:1384–92
   PubMed Web of Science ®Google Scholar
• Miatello R, Vazguez M, Renna N, et al. (2005). Chronic administration of resveratrol prevent biochemical cardiovascular changes in fructose-fed rats. Am J Hypertens 18:864–70
   PubMed Web of Science ®Google Scholar
• Miller A, Adeli K. (2008). Dietary fructose and the metabolic syndrome. Curr Opin Gastroenterol 24:204–9
   PubMed Web of Science ®Google Scholar
• Muhlbauer E, Albrecht E, Bazwinsky-Wutschke I, Peschke E. (2012). Melatonin influences insulin secretion primarily via MT1 receptors in rat insulinoma cells (INS-1) and mouse pancreatic islets. J Pineal Res 52:446–59
   PubMed Web of Science ®Google Scholar
• Murawska-Cialowicz E, Januszewska L, Zuwala-Jagiello J, et al. (2008). Melatonin decreases homocysteine level in blood of rats. J Physiol Pharmacol 59:717–29
   PubMed Web of Science ®Google Scholar
• Nduhirabandi F, du Toit EF, Lochner A. (2012). Melatonin and the metabolic syndrome: A tool for effective therapy in obesity-associated abnormalities? Acta Physiol 205:209–23
   PubMed Web of Science ®Google Scholar
• Okatani Y, Wakatsuki A, Reiter RJ. (2000). Protective effect of melatonin against homocysteine-induced vasoconstriction of human umbilical artery. Biochem Biophys Res Commun 277:470–5
   PubMed Web of Science ®Google Scholar
• Okatani Y, Wakatsuki A, Reiter RJ. (2001). Melatonin suppresses homocysteine enhancement of serotonin-induced vasoconstriction in the human umbilical artery. J Pineal Res 31:242–7
   PubMed Web of Science ®Google Scholar
• Reddy SS, Ramatholisamma P, Karuna R, Saralakumari D. (2009). Preventive effect of Tinospora cordifolia against high-fructose diet-induced insulin resistance and oxidative stress in male Wistar rats. Food Chem Toxicol 47:2224–9
   PubMed Web of Science ®Google Scholar
• Rios-Lugo MJ, Cano P, Jimenez-Ortega V, et al. (2010). Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats. J Pineal Res 49:342–8
   PubMed Web of Science ®Google Scholar
• Robeva R, Kirilov G, Tomova A, Kumanov P. (2008). Melatonin-insulin interactions in patients with metabolic syndrome. J Pineal Res 44:52–6
   PubMed Web of Science ®Google Scholar
• Sanchez-Lozada LG, Tapia E, Jimenez A, et al. (2007). Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 292:F423–9
   PubMed Web of Science ®Google Scholar
• Sartori C, Dessen P, Mathieu C, et al. (2009). Melatonin improves glucose homeostasis and endothelial vascular function in high-fat diet-fed insulin-resistant mice. Endocrinology 150:5311–17
   PubMed Web of Science ®Google Scholar
• Scherrer U, Randin D, Vollenweider P, et al. (1994). Nitric oxide release accounts for insulin's vascular effects in humans. J Clin Invest 94:2511–15
   PubMed Web of Science ®Google Scholar
• Srinivasan V, Ohta Y, Espino J, et al. (2013). Metabolic syndrome, its pathophysiology and the role of melatonin. Recent Pat Endocr Metab Immun Drug Discov 7:11–25
   PubMedGoogle Scholar
• Stühlinger MC, Tsao PS, Her JH, et al. (2001). Homocysteine impairs the nitric oxide synthase pathway: Role of asymmetric dimethylarginine. Circulation 104:2569–75
   PubMed Web of Science ®Google Scholar
• Sydow K, Münzel T. (2003). ADMA and oxidative stress. Atherosclerosis Suppl 4:41–51
   PubMed Web of Science ®Google Scholar
• Tain YL, Hsieh CS, Chen CC, et al. (2010a). Melatonin prevents increased asymmetric dimethylarginine in young rats with bile duct ligation. J Pineal Res 48:212–21
   PubMed Web of Science ®Google Scholar
• Tain YL, Huang LT, Lin IC, et al. (2010b). Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats. J Pineal Res 49:390–8
   PubMed Web of Science ®Google Scholar
• Tain YL, Kao YH, Hsieh CS, et al. (2010c). Melatonin blocks oxidative stress-induced increased asymmetric dimethylarginine. Free Radic Biol Med 49:1088–98
   PubMed Web of Science ®Google Scholar
• Tran LT, Yuen VG, McNeill JH. (2009). The fructose-fed rat: A review on the mechanisms of fructose-induced insulin resistance and hypertension. Mol Cell Biochem 332:145–59
   PubMed Web of Science ®Google Scholar
• Verma S, Skarsgard P, Bhanot S. (1997). Reactivity of mesenteric arteries from fructose hypertensive rats to endothelin-1. Am J Hypertens 10:1010–19
   PubMed Web of Science ®Google Scholar
• Wilcken DE, Wang J, Sim AS, et al. (2006). Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: Relevance of renal function. J Inherit Metab Dis 29:30–7
   PubMed Web of Science ®Google Scholar
• Zanuto R, Siqueira-Filho MA, Caperuto LC, et al. (2013). Melatonin improves insulin sensitivity independently of weight loss in old obese rats. J Pineal Res 55:156–65
   PubMed Web of Science ®Google Scholar